Open AccessSafety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
Author(s) -
Navin Venkatraman,
B Ndiaye,
Georgina Bowyer,
Djibril Wade,
Saranya Sridhar,
Daniel Wright,
Jonathan Powlson,
Ibrahima Ndiaye,
Siry Dièye,
Craig Thompson,
Momar Bakhoum,
Richard Morter,
Stefania Capone,
Mariarosaria Del Sorbo,
Sophie Jamieson,
Tommy Rampling,
Mehreen S. Datoo,
Rachel Roberts,
Ian Poulton,
Oliver Griffiths,
W. Ripley Ballou,
François Roman,
David Lewis,
Alison M. Lawrie,
Egeruan Babatunde Imoukhuede,
Sarah C. Gilbert,
Tandakha N. Dieye,
Katie Ewer,
Souleymane Mboup,
Adrian V. S. Hill
Publication year - 2018
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiy639
Subject(s) - modified vaccinia ankara , ebola vaccine , immunogenicity , virology , ebola virus , regimen , medicine , vaccination , immunology , outbreak , vaccinia , biology , immune system , recombinant dna , biochemistry , gene
The 2014 West African outbreak of Ebola virus disease highlighted the urgent need to develop an effective Ebola vaccine.